• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国心脏死亡后器官捐献的试点项目。

A pilot programme of organ donation after cardiac death in China.

机构信息

Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, China.

出版信息

Lancet. 2012 Mar 3;379(9818):862-5. doi: 10.1016/S0140-6736(11)61086-6. Epub 2011 Nov 10.

DOI:10.1016/S0140-6736(11)61086-6
PMID:22078722
Abstract

China's aims are to develop an ethical and sustainable organ transplantation system for the Chinese people and to be accepted as a responsible member of the international transplantation community. In 2007, China implemented the Regulation on Human Organ Transplantation, which was the first step towards the establishment of a voluntary organ donation system. Although progress has been made, several ethical and legal issues associated with transplantation in China remain, including the use of organs from executed prisoners, organ scarcity, the illegal organ trade, and transplantation tourism. In this Health Policy article we outline the standards used to define cardiac death in China and a legal and procedural framework for an organ donation system based on voluntary donation after cardiac death that adheres to both China's social and cultural principles and international transplantation standards.

摘要

中国的目标是为中国人民开发一个符合伦理且可持续的器官移植体系,并成为国际移植界负责任的一员。2007 年,中国实施了《人体器官移植条例》,这是建立自愿器官捐献体系的第一步。尽管已经取得了一些进展,但中国的器官移植仍然存在一些伦理和法律问题,包括使用死刑犯器官、器官短缺、非法器官交易和器官移植旅游等。在这篇卫生政策文章中,我们概述了中国用来定义心死亡的标准,以及一个基于心死亡后自愿捐献的器官捐献系统的法律和程序框架,该框架既符合中国的社会和文化原则,也符合国际移植标准。

相似文献

1
A pilot programme of organ donation after cardiac death in China.中国心脏死亡后器官捐献的试点项目。
Lancet. 2012 Mar 3;379(9818):862-5. doi: 10.1016/S0140-6736(11)61086-6. Epub 2011 Nov 10.
2
The transplant surgeon and transplant tourists: ethical and surgical issues.移植外科医生与移植游客:伦理与外科问题。
Am J Bioeth. 2010 Feb;10(2):12-3. doi: 10.1080/15265160903506434.
3
Transplant tourism in China: a tale of two transplants.中国的器官移植旅游:两次移植的故事。
Am J Bioeth. 2010 Feb;10(2):3-11. doi: 10.1080/15265160903558781.
4
Moral complexity and the delusion of moral purity.道德复杂性与道德纯洁的错觉。
Am J Bioeth. 2010 Feb;10(2):W1-3. doi: 10.1080/15265160903558807.
5
Historical development and current status of organ procurement from death-row prisoners in China.中国死囚器官获取的历史发展与现状
BMC Med Ethics. 2015 Dec 3;16(1):85. doi: 10.1186/s12910-015-0074-0.
6
Human rights violations in organ procurement practice in China.中国器官获取行为中的侵犯人权现象。
BMC Med Ethics. 2017 Feb 8;18(1):11. doi: 10.1186/s12910-017-0169-x.
7
Organ transplantation in China--the 21st century.21世纪的中国器官移植
Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):346-8. doi: 10.1016/s1499-3872(12)60191-x.
8
Smoke and mirrors: unanswered questions and misleading statements obscure the truth about organ sources in China.烟雾与镜子:未解答的问题和误导性陈述掩盖了中国器官来源的真相。
J Med Ethics. 2016 Aug;42(8):552-3. doi: 10.1136/medethics-2016-103533. Epub 2016 May 4.
9
Transplant Ethics.移植伦理学
Exp Clin Transplant. 2016 Nov;14(Suppl 3):32-36.
10
A call for a policy change regarding publications based on transplantation of organs from executed prisoners.呼吁改变关于基于处决囚犯器官移植的出版物的政策。
J Heart Lung Transplant. 2012 Jun;31(6):555-6. doi: 10.1016/j.healun.2012.03.003. Epub 2012 Apr 6.

引用本文的文献

1
Influence of portal hypertension-associated upper gastrointestinal bleeding and acute kidney injury on liver transplantation prognosis.门静脉高压相关性上消化道出血及急性肾损伤对肝移植预后的影响。
Perioper Med (Lond). 2025 Jun 3;14(1):61. doi: 10.1186/s13741-025-00545-5.
2
Emerging trends and hotspots in animal experimental research on lung transplantation from 2004 to 2023: a bibliometric analysis.2004年至2023年肺移植动物实验研究的新兴趋势与热点:一项文献计量分析
J Thorac Dis. 2025 Feb 28;17(2):796-815. doi: 10.21037/jtd-24-1451. Epub 2025 Feb 27.
3
Prediction model of the T cell-mediated rejection after liver transplantation in children and adults: A case-controlled study.
儿童和成人肝移植后T细胞介导排斥反应的预测模型:一项病例对照研究。
Int J Surg. 2025 Apr 1;111(4):2827-2837. doi: 10.1097/JS9.0000000000002279.
4
Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.肝移植前门静脉减压是否会影响肝癌复发?一项巢式病例对照研究。
BMC Cancer. 2024 May 3;24(1):558. doi: 10.1186/s12885-024-12322-6.
5
Hypothermic machine perfusion reduces donation after circulatory death liver ischemia-reperfusion injury through the SERPINA3-mediated PI3Kδ/Akt pathway.低温机器灌注通过 SERPINA3 介导的 PI3Kδ/Akt 通路减少循环死亡供肝缺血再灌注损伤。
Hum Cell. 2024 Mar;37(2):420-434. doi: 10.1007/s13577-023-01012-3. Epub 2023 Dec 22.
6
A bibliometric and visualized analysis of hepatic ischemia-reperfusion injury (HIRI) from 2002 to 2021.2002年至2021年肝缺血再灌注损伤(HIRI)的文献计量学与可视化分析
Heliyon. 2023 Nov 19;9(11):e22644. doi: 10.1016/j.heliyon.2023.e22644. eCollection 2023 Nov.
7
First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China: 5-year Experience at a High-volume Donor and Recipient Liver Transplant Center.中国广州中山大学附属第一医院:高容量供体和受体肝移植中心的5年经验。
Transplantation. 2023 Sep 1;107(9):1855-1859. doi: 10.1097/TP.0000000000004561. Epub 2023 Aug 21.
8
Effect of Perioperative Dexmedetomidine on Delayed Graft Function Following a Donation-After-Cardiac-Death Kidney Transplant: A Randomized Clinical Trial.心脏死亡后供肾移植中围手术期右美托咪定对延迟移植物功能的影响:一项随机临床试验。
JAMA Netw Open. 2022 Jun 1;5(6):e2215217. doi: 10.1001/jamanetworkopen.2022.15217.
9
Execution by organ procurement: Breaching the dead donor rule in China.器官获取执行人:中国打破了死亡器官捐献者规则。
Am J Transplant. 2022 Jul;22(7):1804-1812. doi: 10.1111/ajt.16969. Epub 2022 Apr 4.
10
Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors.索磷布韦/维帕他韦预防方案用于接受 HCV 阳性供者肾移植的 HCV 阴性受者 12 周。
Ann Transplant. 2021 Sep 7;26:e933313. doi: 10.12659/AOT.933313.